DE1793465A1 - Neues Salz des Heptaminols und Verfahren zu seiner Herstellung - Google Patents
Neues Salz des Heptaminols und Verfahren zu seiner HerstellungInfo
- Publication number
- DE1793465A1 DE1793465A1 DE19681793465 DE1793465A DE1793465A1 DE 1793465 A1 DE1793465 A1 DE 1793465A1 DE 19681793465 DE19681793465 DE 19681793465 DE 1793465 A DE1793465 A DE 1793465A DE 1793465 A1 DE1793465 A1 DE 1793465A1
- Authority
- DE
- Germany
- Prior art keywords
- heptaminol
- preparation
- new salt
- dog
- page
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 9
- LREQLEBVOXIEOM-UHFFFAOYSA-N 6-amino-2-methyl-2-heptanol Chemical compound CC(N)CCCC(C)(C)O LREQLEBVOXIEOM-UHFFFAOYSA-N 0.000 title description 3
- 229960005402 heptaminol Drugs 0.000 title description 3
- 150000003839 salts Chemical class 0.000 title description 3
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 229910014033 C-OH Inorganic materials 0.000 claims 1
- 229910014570 C—OH Inorganic materials 0.000 claims 1
- 230000000694 effects Effects 0.000 description 9
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229940114081 cinnamate Drugs 0.000 description 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 4
- 241000282326 Felis catus Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JZNBMCOSOXIZJB-UHFFFAOYSA-N 6-amino-2-methylheptan-2-ol;hydron;chloride Chemical compound Cl.CC(N)CCCC(C)(C)O JZNBMCOSOXIZJB-UHFFFAOYSA-N 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002908 adrenolytic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229960004344 heptaminol hydrochloride Drugs 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- -1 polyoxyethylene Polymers 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000003424 uricosuric effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- E—FIXED CONSTRUCTIONS
- E06—DOORS, WINDOWS, SHUTTERS, OR ROLLER BLINDS IN GENERAL; LADDERS
- E06B—FIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES
- E06B9/00—Screening or protective devices for wall or similar openings, with or without operating or securing mechanisms; Closures of similar construction
- E06B9/02—Shutters, movable grilles, or other safety closing devices, e.g. against burglary
- E06B9/08—Roll-type closures
- E06B9/11—Roller shutters
- E06B9/15—Roller shutters with closing members formed of slats or the like
- E06B9/165—Roller shutters with closing members formed of slats or the like with slats disappearing in each other; with slats the distance between which can be altered
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Structural Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Civil Engineering (AREA)
- Medicinal Chemistry (AREA)
- Architecture (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19681793465 DE1793465A1 (de) | 1968-09-20 | 1968-09-20 | Neues Salz des Heptaminols und Verfahren zu seiner Herstellung |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19681793465 DE1793465A1 (de) | 1968-09-20 | 1968-09-20 | Neues Salz des Heptaminols und Verfahren zu seiner Herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE1793465A1 true DE1793465A1 (de) | 1971-07-22 |
| DE1793465C3 DE1793465C3 (enrdf_load_stackoverflow) | 1973-01-04 |
Family
ID=5707715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19681793465 Granted DE1793465A1 (de) | 1968-09-20 | 1968-09-20 | Neues Salz des Heptaminols und Verfahren zu seiner Herstellung |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE1793465A1 (enrdf_load_stackoverflow) |
-
1968
- 1968-09-20 DE DE19681793465 patent/DE1793465A1/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE1793465C3 (enrdf_load_stackoverflow) | 1973-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69003229T2 (de) | Entzündungshemmendes Mittel in einer Zusammensetzung. | |
| DE69106656T2 (de) | Tanninextrakt von Kastanienholz, Verfahren zu deren Herstellung und deren Verwendung. | |
| DE1670005C2 (de) | β-(4,5-Diphenyloxazol-2-yl)-propionsäure oder ein pharmazeutisch verträgliches Salz davon, Verfahren zur Herstellung dieser Verbindungen und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten | |
| DE2040578A1 (de) | Neue Medikamente auf der Grundlage von Monoamiden von cyclischen Dicarbonsaeuren,insbesondere der Phthalsaeure,und Verfahren zu deren Herstellung | |
| DE1793465A1 (de) | Neues Salz des Heptaminols und Verfahren zu seiner Herstellung | |
| CH638681A5 (en) | Pharmaceutical containing Echinacea and lactic acid derivatives and process for its preparation | |
| DE2660486C2 (de) | Verwendung von 2-Hydroxymethyl-3,4,5-trihydroxypiperidin als Arzneimittel | |
| DE2333831C3 (de) | l-(2-Benzoyl-äthyl)-2-(4-a- cinnamylpiperazinomethyQ-benzimidazole, Verfahren zur ihrer Herstellung und ihre therapeutische Verwendung | |
| DE1967324C2 (de) | 3-(3,4,5-Trimethoxybenzamido)-piperidin, Verfahren zu dessen Herstellung und die Verbindung enthaltende Arzneimittel | |
| DE2609746A1 (de) | Piperazinverbindungen sowie arzneimittel, die diese verbindungen enthalten | |
| DE3205149C2 (enrdf_load_stackoverflow) | ||
| DE2038628B2 (de) | N,N'-Di(carboxyalkyl)-p-phenylendiamine, deren Salze und Diäthylester, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE2521905C2 (de) | Arzneimittel zur cerebralen Durchblutungsförderung | |
| DE1936723A1 (de) | Alkaloidsalze der Chinarinde und Verfahren zu ihrer Herstellung | |
| DE1695284B2 (de) | Substituierte-2-amino-4,5-diphenyl- oxazolderivate | |
| AT319934B (de) | Vzh der neuen 5-n-pyrrylsalicylsaeure und ihrer salze | |
| DE2019306C3 (de) | 1-Naphthyl-l-hydroxyacetamidine und diese enthaltende Arzneimittel | |
| DE1767666B2 (de) | Pharmazeutische Zubereitung gegen , Lebererkrankungen | |
| DE1767352C (de) | Subkutan zu verabreichendes Veterinär-Arzneimittel zur Verbesserung des Fleischansatzes | |
| DE2228289C2 (de) | 1-(6-Hydroxyhexyl)-2(1H)-pyridinon | |
| DE1793465B (de) | Salz der Zimtsaure mit 6 Ammo 2 methyl 2 heptanol | |
| DE1933179C3 (de) | 2-Benzimfdazolylmethyl-piperazinderivate, deren Maleate, Verfahren zu Ihrer Herstellung und Arzneimittel | |
| DE2501649A1 (de) | Thiophen-carbonsaeuresalze des papaverins, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel | |
| AT330748B (de) | Verfahren zur herstellung von neuen 1- phenoxy-2-hydroxy-3-propargylaminopropanen und von deren saureadditionssalzen | |
| DE1935697A1 (de) | Brom-5-Isatin in seiner Eigenschaft als neuartiges schmerzlinderndes und beruhigendes Medikament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| 8339 | Ceased/non-payment of the annual fee |